Genome-Wide Association Study of Blood Pressure Extremes Identifies Variant near Associated with Hypertension
Hypertension is a heritable and major contributor to the global burden of disease. The sum of rare and common genetic variants robustly identified so far explain only 1%–2% of the population variation in BP and hypertension. This suggests the existence of more undiscovered common variants. We conducted a genome-wide association study in 1,621 hypertensive cases and 1,699 controls and follow-up validation analyses in 19,845 cases and 16,541 controls using an extreme case-control design. We identified a locus on chromosome 16 in the 5′ region of Uromodulin (UMOD; rs13333226, combined P value of 3.6×10−11). The minor G allele is associated with a lower risk of hypertension (OR [95%CI]: 0.87 [0.84–0.91]), reduced urinary uromodulin excretion, better renal function; and each copy of the G allele is associated with a 7.7% reduction in risk of CVD events after adjusting for age, sex, BMI, and smoking status (H.R. = 0.923, 95% CI 0.860–0.991; p = 0.027). In a subset of 13,446 individuals with estimated glomerular filtration rate (eGFR) measurements, we show that rs13333226 is independently associated with hypertension (unadjusted for eGFR: 0.89 [0.83–0.96], p = 0.004; after eGFR adjustment: 0.89 [0.83–0.96], p = 0.003). In clinical functional studies, we also consistently show the minor G allele is associated with lower urinary uromodulin excretion. The exclusive expression of uromodulin in the thick portion of the ascending limb of Henle suggests a putative role of this variant in hypertension through an effect on sodium homeostasis. The newly discovered UMOD locus for hypertension has the potential to give new insights into the role of uromodulin in BP regulation and to identify novel drugable targets for reducing cardiovascular risk.
Vyšlo v časopise:
Genome-Wide Association Study of Blood Pressure Extremes Identifies Variant near Associated with Hypertension. PLoS Genet 6(10): e32767. doi:10.1371/journal.pgen.1001177
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1001177
Souhrn
Hypertension is a heritable and major contributor to the global burden of disease. The sum of rare and common genetic variants robustly identified so far explain only 1%–2% of the population variation in BP and hypertension. This suggests the existence of more undiscovered common variants. We conducted a genome-wide association study in 1,621 hypertensive cases and 1,699 controls and follow-up validation analyses in 19,845 cases and 16,541 controls using an extreme case-control design. We identified a locus on chromosome 16 in the 5′ region of Uromodulin (UMOD; rs13333226, combined P value of 3.6×10−11). The minor G allele is associated with a lower risk of hypertension (OR [95%CI]: 0.87 [0.84–0.91]), reduced urinary uromodulin excretion, better renal function; and each copy of the G allele is associated with a 7.7% reduction in risk of CVD events after adjusting for age, sex, BMI, and smoking status (H.R. = 0.923, 95% CI 0.860–0.991; p = 0.027). In a subset of 13,446 individuals with estimated glomerular filtration rate (eGFR) measurements, we show that rs13333226 is independently associated with hypertension (unadjusted for eGFR: 0.89 [0.83–0.96], p = 0.004; after eGFR adjustment: 0.89 [0.83–0.96], p = 0.003). In clinical functional studies, we also consistently show the minor G allele is associated with lower urinary uromodulin excretion. The exclusive expression of uromodulin in the thick portion of the ascending limb of Henle suggests a putative role of this variant in hypertension through an effect on sodium homeostasis. The newly discovered UMOD locus for hypertension has the potential to give new insights into the role of uromodulin in BP regulation and to identify novel drugable targets for reducing cardiovascular risk.
Zdroje
1. EzzatiM
LopezAD
RodgersA
VanderHS
MurrayCJ
2002 Selected major risk factors and global and regional burden of disease. Lancet 360 1347 1360
2. KearneyPM
WheltonM
ReynoldsK
MuntnerP
WheltonPK
2005 Global burden of hypertension: analysis of worldwide data. Lancet 365 217 223
3. LewingtonS
ClarkeR
QizilbashN
PetoR
CollinsR
2002 Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 1903 1913
4. ChobanianAV
BakrisGL
BlackHR
CushmanWC
GreenLA
2003 The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 2560 2572
5. ManciaG
De BackerG
DominiczakA
CifkovaR
FagardR
2007 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25 1751 1762
6. SegaR
FacchettiR
BombelliM
CesanaG
CorraoG
2005 Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 111 1777 1783
7. CutlerJA
SorliePD
WolzM
ThomT
FieldsLE
2008 Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension 52 818 827
8. LevyD
EhretGB
RiceK
VerwoertGC
LaunerLJ
2009 Genome-wide association study of blood pressure and hypertension. Nat Genet 41 677 687
9. Newton-ChehC
JohnsonT
GatevaV
TobinMD
BochudM
2009 Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 41 666 676
10. The Wellcome Trust Case Control Consortium 2007 Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 661 678
11. SmithJG
PlatonovPG
HedbladB
EngstromG
MelanderO
2010 Atrial fibrillation in the Malmo diet and cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 25 2 95 102
12. IwaiN
KajimotoK
KokuboY
TomoikeH
2006 Extensive genetic analysis of 10 candidate genes for hypertension in Japanese. Hypertension 48 901 907
13. KottgenA
GlazerNL
DehghanA
HwangSJ
KatzR
2009 Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 41 712 717
14. BachmannS
MetzgerR
BunnemannB
1990 Tamm-Horsfall protein-mRNA synthesis is localized to the thick ascending limb of Henle's loop in rat kidney. Histochemistry and Cell Biology 94 517 523
15. MalagoliniN
CavalloneD
Serafini-CessiF
1997 Intracellular transport, cell-surface exposure and release of recombinant Tamm-Horsfall glycoprotein. Kidney Int 52 1340 1350
16. HartTC
GorryMC
HartPS
WoodardAS
ShihabiZ
2002 Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 39 882 892
17. RampoldiL
CaridiG
SantonD
BoarettoF
BernasconeI
2003 Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. Hum Mol Genet 12 3369 3384
18. Vylet'alP
KublovaM
KalbacovaM
HodanovaK
BaresovaV
2006 Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome. Kidney Int 70 1155 1169
19. TorffvitO
JorgensenPE
KamperAL
Holstein-RathlouNH
LeyssacPP
1998 Urinary excretion of Tamm-Horsfall protein and epidermal growth factor in chronic nephropathy. Nephron 79 167 172
20. ZurbigP
DecramerS
DaknaM
JantosJ
GoodDM
2009 The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease. Proteomics 9 2108 2117
21. DulawaJ
KokotF
KokotM
PanderH
1998 Urinary excretion of Tamm-Horsfall protein in normotensive and hypertensive elderly patients. J Hum Hypertens 12 635 637
22. TorffvitO
AgardhCD
ThulinT
1999 A study of Tamm-Horsfall protein excretion in hypertensive patients and type 1 diabetic patients. Scand J Urol Nephrol 33 187 191
23. LiftonRP
2004 Genetic dissection of human blood pressure variation: common pathways from rare phenotypes. Harvey Lect 100 71 101
24. JiW
FooJN
O'RoakBJ
ZhaoH
LarsonMG
2008 Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 40 592 599
25. HanssonL
HednerT
Lund-JohansenP
KjeldsenSE
LindholmLH
2000 Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet 356 359 365
26. BerglundG
ElmstahlS
JanzonL
LarssonSA
1993 The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med 233 45 51
27. KathiresanS
MelanderO
AnevskiD
GuiducciC
BurttNP
2008 Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 358 1240 1249
28. FerrarioM
SegaR
CesanaGC
1991 Lessons from the MONICA Study in Northern Italy. J Hypertens 9 S7 S14
29. LyssenkoV
JonssonA
AlmgrenP
PulizziN
IsomaaB
2008 Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359 2220 2232
30. LichtCM
de GeusEJ
SeldenrijkA
van HoutHP
ZitmanFG
2009 Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension 53 631 638
31. LeveyAS
BoschJP
LewisJB
GreeneT
RogersN
1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 461 470
32. CaulfieldM
MunroeP
PembrokeJ
SamaniN
DominiczakA
2003 Genome-wide mapping of human loci for essential hypertension. Lancet 361 2118 2123
33. VisserFW
MuntingaJH
DierckxRA
NavisG
2008 Feasibility and impact of the measurement of extracellular fluid volume simultaneous with GFR by 125I-iothalamate. Clin J Am Soc Nephrol 3 1308 1315
34. VisserFW
BoonstraAH
TitiaLA
BoomsmaF
NavisG
2008 Renal response to angiotensin II is blunted in sodium-sensitive normotensive men. Am J Hypertens 21 323 328
35. BochudM
BovetP
VollenweiderP
MaillardM
PaccaudF
2009 Association between white-coat effect and blunted dipping of nocturnal blood pressure. Am J Hypertens 22 1054 1061
36. BochudM
StaessenJA
MaillardM
MazekoMJ
KuznetsovaT
2009 Ethnic differences in proximal and distal tubular sodium reabsorption are heritable in black and white populations. J Hypertens 27 606 612
37. PriceAL
PattersonNJ
PlengeRM
WeinblattME
ShadickNA
2006 Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38 904 909
38. MarchiniJ
HowieB
MyersS
McVeanG
DonnellyP
2007 A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39 906 913
39. DevlinB
RoederK
1999 Genomic control for association studies. Biometrics 55 997 1004
40. McCarthyMI
AbecasisGR
CardonLR
GoldsteinDB
LittleJ
2008 Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9 356 369
41. TobinMD
SheehanNA
ScurrahKJ
BurtonPR
2005 Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 24 2911 2935
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2010 Číslo 10
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Genome-Wide Identification of Targets and Function of Individual MicroRNAs in Mouse Embryonic Stem Cells
- Common Genetic Variants and Modification of Penetrance of -Associated Breast Cancer
- Allele-Specific Down-Regulation of Expression Induced by Retinoids Contributes to Climate Adaptations
- Simultaneous Disruption of Two DNA Polymerases, Polη and Polζ, in Avian DT40 Cells Unmasks the Role of Polη in Cellular Response to Various DNA Lesions